Cytek Biosciences, Inc. (CTKB): Capital Expenditures
$4.08M
Year ended 2025-12-31
$6.04M
Trailing 12 months to 2026-06-30
-25.2%
3-year compound annual growth
+21.4%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.08M | +15.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $3.52M | -24.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $4.65M | -52.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $9.75M | +123.4% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $4.36M | +182.1% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $1.55M | n/a | 2023-03-01, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $4.08M | +15.9% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $2.71M | -56.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $2.61M | -22.4% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $1.26M | -52.4% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $5.93M | -52.1% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $955.0K | +58.6% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $850.0K | -37.7% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $3.28M | -19.1% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $326.0K | +46.2% |
Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗